Clinical Report: Assessing Evidence for Genicular Artery Embolization in Knee Osteoarthritis

Overview

The letter argues that the 12-month sham-controlled trial of genicular artery embolization (GAE) for knee osteoarthritis found no significant between-group difference in pain, but its design limitations prevent firm conclusions about efficacy. It highlights inadequate statistical power, incomplete embolization in some assigned participants, limited baseline synovitis, and potential limitations in MRI assessment.

Background

Knee osteoarthritis affects more than 500 million people worldwide and is a major cause of chronic musculoskeletal pain. The letter describes a therapeutic gap for patients whose symptoms remain insufficiently controlled with conservative treatment and who may not undergo surgery. GAE targets synovial hypervascularity and neoangiogenesis, and animal findings cited in the letter associate embolization with reduced synovitis and inflammatory cell infiltration. The authors therefore emphasize the importance of matching trial eligibility and assessment methods to the procedure’s proposed inflammatory target.

Data Highlights

Key Findings

• The 12-month follow-up, like the previously reported 4-month findings, showed no significant between-group difference in pain improvement.
• The letter states that the trial was underpowered: the sham response was 18.4 KOOS-Pain points rather than the 8 points assumed in the sample-size calculation, and only 29 participants were enrolled per group.
• The authors caution that a non-significant result does not establish equivalence; the reported confidence interval remained compatible with a difference exceeding the stated minimal clinically important difference.
• Three of 29 participants assigned to GAE had no angiographic blush and did not undergo embolization, reducing the biological separation between groups despite inclusion in the intention-to-treat analysis.
• The letter cites Landers et al. as reporting clinically relevant improvement in 77% of patients receiving multi-vessel embolization versus 38% of controls, and argues that complete multi-vessel treatment and procedural experience warrant consideration in trial design.
• The authors question whether the trial adequately tested an intervention directed at synovitis: baseline scores suggested borderline inflammatory activity, eligibility was based on Kellgren-Lawrence grade rather than MRI-confirmed synovitis, and MRI assessment ended at 4 months. They also report that one reader performed all MRI analyses and assessed clinical outcomes, with no inter- or intra-reader reliability data provided.

Clinical Implications

The letter advises cautious interpretation of the trial and states that its findings do not permit premature conclusions about clinical efficacy. It identifies patient selection for clinically meaningful synovitis, complete multi-vessel embolization, adequate statistical power, longer imaging follow-up, and reader-reliability assessment as issues for future evaluation.

Conclusion

The 12-month trial reported no significant between-group pain difference, but the letter identifies methodological limitations that constrain interpretation. The authors argue that the available findings neither establish GAE efficacy nor rule out a clinically meaningful benefit.

Related Resources & Content

1. Van Zadelhoff et al., European Radiology, 2026 — Long-term outcomes of genicular artery embolization for knee osteoarthritis: 12-month efficacy and secondary outcomes from a randomized sham-controlled clinical trial
2. European Radiology, 2025 — Timely Genicular Artery Embolization for Knee Osteoarthritis Linked to Enhanced Clinical Outcomes
3. U.S. Department of Veterans Affairs and Department of Defense, 2026 — Clinical Practice Guideline for the Non-Surgical Management of Hip & Knee Osteoarthritis
4. Society of Interventional Radiology, 2026 — New position statement highlights the growing role of genicular artery embolization for knee osteoarthritis
5. reuters — Artery Block May Cut Knee Pain by 71%
6. Pain Medicine — Effect of ultrasound-guided genicular nerve neurolysis versus sham procedure on pain in patients with knee osteoarthritis: a randomized clinical trial
7. VA/DoD Clinical Practice Guideline for the Non-Surgical Management of Hip & Knee Osteoarthritis
8. Society of Interventional Radiology position statement on genicular artery embolization for knee osteoarthritis
9. Preserving joint healthspan in knee osteoarthritis: a geroscience-guided review of non-surgical therapies and genicular artery embolization - PMC
10. Long-term outcomes of genicular artery embolization for knee osteoarthritis: 12-month efficacy and secondary outcomes from a randomized sham-controlled clinical trial | European Radiology | Springer Nature Link
11. https://boneandjoint.org.uk/article/10.1302/2633-1462.43.BJO-2022-0161.R2/pdf
12. Genicular artery embolization as a minimally invasive treatment for knee osteoarthritis: systematic review and meta-analysis - PubMed